Grant of options

RNS Number : 7678O
Synairgen plc
22 September 2011
 



22 September 2011

 

Synairgen plc ('Synairgen' or the 'Company')

 

Grant of options

 

On 21 September 2011 the board of Synairgen granted options ("Options") over 2,126,469 ordinary shares of one pence each in the capital of the Company ("Ordinary Shares") at an exercise price of one pence per Ordinary Share. The Options represent in aggregate 3.06 per cent. of the existing issued share capital.

 

The Options are issued under the Company's existing Long Term Incentive Plan and are exercisable between 21 September 2014 and 20 September 2021, subject to achievement of performance criteria related to the increase in the total shareholder return of the Company.

 

The following Options were issued to directors of the Company on 21 September 2011:

 

Director

Options Issued

Richard Marsden

538,063

John Ward

489,148

Dr. Phillip Monk

400,212

 

 Following the issue of the Options, the interests of the directors of the Company at 21 September 2011 are as follows:

 

Director

Total Options Issued

Ordinary Shares

Total Interest

% of issued share capital

Richard Marsden

2,342,032

95,860

2,437,892

3.50%

John Ward

1,772,756

228,788

2,001,544

2.88%

Dr. Phillip Monk

1,235,971

18,518

1,254,489

1.80%

Iain Buchanan

212,765

92,592

305,357

0.44%

Dr. David Campbell

-

253,960

253,960

0.37%

Paul Clegg

250,000

184,095

434,095

0.62%

 

Prof. Stephen Holgate (Note 1)

-

852,316

852,316

1.23%

Simon Shaw

-

1,368,580

1,368,580

1.97%

 

Note 1. The holding of Professor Stephen Holgate includes 1,923 Ordinary Shares registered in the name of Professor Holgate's wife.

 

For further information, please contact:

 

Synairgen plc                                                            Tel: + 44 (0) 23 8051 2800

Richard Marsden, Chief Executive Officer

John Ward, Finance Director

 

FinnCap                                                                    Tel: + 44 (0) 20 7220 0500

Geoff Nash (Corporate Finance)

Stephen Norcross, Simon Starr (Corporate Broking)


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEALNAAEXFEFF

Companies

Synairgen (SNG)
UK 100

Latest directors dealings